Dietrich John Pauls - Net Worth and Insider Trading
Dietrich John Pauls Net Worth
The estimated net worth of Dietrich John Pauls is at least $198,914 dollars as of 2024-05-22. Dietrich John Pauls is the President and CEO of DiaMedica Therapeutics Inc and owns about 68,591 shares of DiaMedica Therapeutics Inc (DMAC) stock worth over $198,914. Details can be seen in Dietrich John Pauls's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Dietrich John Pauls has not made any transactions after 2023-06-23 and currently still holds the listed stock(s).
Transaction Summary of Dietrich John Pauls
Dietrich John Pauls Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dietrich John Pauls owns 1 companies in total, including DiaMedica Therapeutics Inc (DMAC) .
Click here to see the complete history of Dietrich John Pauls’s form 4 insider trades.
Insider Ownership Summary of Dietrich John Pauls
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DMAC | DiaMedica Therapeutics Inc | 2023-06-23 | director & President and CEO |
Dietrich John Pauls Latest Holdings Summary
Dietrich John Pauls currently owns a total of 1 stock. Dietrich John Pauls owns 68,591 shares of DiaMedica Therapeutics Inc (DMAC) as of June 23, 2023, with a value of $198,914.
Latest Holdings of Dietrich John Pauls
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DMAC | DiaMedica Therapeutics Inc | 2023-06-23 | 68,591 | 2.90 | 198,914 |
Holding Weightings of Dietrich John Pauls
Dietrich John Pauls Form 4 Trading Tracker
According to the SEC Form 4 filings, Dietrich John Pauls has made a total of 3 transactions in DiaMedica Therapeutics Inc (DMAC) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in DiaMedica Therapeutics Inc is the acquisition of 12,787 shares on June 23, 2023, which cost Dietrich John Pauls around $49,997.
Insider Trading History of Dietrich John Pauls
- 1
Dietrich John Pauls Trading Performance
GuruFocus tracks the stock performance after each of Dietrich John Pauls's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dietrich John Pauls is 5.08%. GuruFocus also compares Dietrich John Pauls's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dietrich John Pauls within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Dietrich John Pauls's insider trading performs compared to the benchmark.
Performance of Dietrich John Pauls
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.4 | | | | | |
| Relative Return to S&P 500(%) | 2.75 | | | | | |
Dietrich John Pauls Ownership Network
Dietrich John Pauls Owned Company Details
What does DiaMedica Therapeutics Inc do?
Who are the key executives at DiaMedica Therapeutics Inc?
Dietrich John Pauls is the director & President and CEO of DiaMedica Therapeutics Inc. Other key executives at DiaMedica Therapeutics Inc include CFO and Secretary Scott Kellen , 10 percent owner Ab Tomenterprise , and 10 percent owner Koch Thomas Von .
DiaMedica Therapeutics Inc (DMAC) Insider Trades Summary
Over the past 18 months, Dietrich John Pauls made 1 insider transaction in DiaMedica Therapeutics Inc (DMAC) with a net purchase of 12,787. Other recent insider transactions involving DiaMedica Therapeutics Inc (DMAC) include a net purchase of 215,000 shares made by Randall Michael Giuffre , a net purchase of 1,470,588 shares made by Koch Thomas Von , and a net purchase of 527,114 shares made by David J. Wambeke .
In summary, during the past 3 months, insiders sold 0 shares of DiaMedica Therapeutics Inc (DMAC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,855,847 shares of DiaMedica Therapeutics Inc (DMAC) were sold and 5,177,486 shares were bought by its insiders, resulting in a net purchase of 2,321,639 shares.
DiaMedica Therapeutics Inc (DMAC)'s detailed insider trading history can be found in Insider Trading Tracker table.
DiaMedica Therapeutics Inc Insider Transactions
Dietrich John Pauls Mailing Address
Above is the net worth, insider trading, and ownership report for Dietrich John Pauls. You might contact Dietrich John Pauls via mailing address: 2 Carlson Parkway, Suite 260, Minneapolis Mn 55447.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
